Melanocytes and Melanoma Etiology


Melanocytes are pigment-producing cells originated from the neural crest. Epidermal melanocytes contribute to photoprotection and thermoregulation by packaging melanin pigment intomelanosomes and sending them to keratinocytes. There are still many gaps in the understanding of early events of melanocyte differentiation and advanced melanoma regarding genetic and molecular processes. In this review, the authors present a summary of the main aspects of the melanocyte biology and its relation with the melanoma etiology, which are of major importance for guiding novel therapies development and to well understand this disease.

Share and Cite:

Brandão, M. , de Oliveira Rocha, B. , Fernandes, J. and de Freitas, L. (2014) Melanocytes and Melanoma Etiology. Open Access Library Journal, 1, 1-7. doi: 10.4236/oalib.1100666.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Rigel, D.S. and Carucci, J.A. (2000) Malignant Melanoma: Prevention, Early Detection, and Treatment in the 21st Century. CA: A Cancer Journal for Clinicians, 50, 215-236.
[2] Friedman, R.J., Rigel, D.S., Silverman, M.K., et al. (1991) Malignant Melanoma in the 1990s: The Continued Importance of Early Detection and the Role of Physician Examination and Self-Examination of the Skin. CA: A Cancer Journal for Clinicians, 41, 201-226.
[3] Le Douarin, N.M. (1986) Cell Line Segregation during Peripheral Nervous System Ontogeny. Science, 231, 1515-1522.
[4] Erickson, C.A. (1993) From the Crest to the Periphery: Control of Pigment Cell Migration and Segregation. Pigment Cell Research, 6, 336-347.
[5] Shivers, S.C., Wang, X., Li, W., et al. (1998) Molecular Staging of Malignant Melanoma: Correlation with Clinical Outcome. JAMA, 280, 1410-1415.
[6] Kobayashi, N., Nakagawa, A., Muramatsu, T., et al. (1998) Supranuclear Melanin Caps Reduce Ultraviolet Induced DNA Photoproducts in Human Epidermis. Journal of Investigative Dermatology, 110, 806-810.
[7] Gilchrest, B.A., Eller, M.S., Geller, A.C., et al. (1999) The Pathogenesis of Melanoma Induced by Ultraviolet Radiation. The New England Journal of Medicine, 340, 1341-1348.
[8] Plettenberg, A. (1995) Human Melanocytes and Melanoma Cells Constitutively Express the Bcl-Photo-Onocogene in Situ and in Cell Culture. American Journal of Pathology, 146, 651-659.
[9] Dubertret, L. (1998) Daily Photo Protection. 7th Congress of the European Academy of Dermatology and Venereology, Nice.
[10] McKay, B.C., Francis, M.A. and Rainbow, A.J. (1997) Wildtype p53 Is Required for Heat Shock and Ultraviolet Light Enhanced Repair of a UV-Damaged Reporter Gene. Carcinogenesis, 18, 245-249.
[11] Le, X.C., Xing, J.Z., Lee, J., et al. (1998) Inducible Repair of Thymine Glycol Detected by an Ultra Sensitive Assay for DNA Damage. Science, 280, 1066-1069.
[12] Eller, M.S., Maeda, T., Magnoni, C., et al. (1997) Enhancement of DNA Repair in Human Skin Cells by Thymidine Nucleotides: Evidence for a p53 Mediated Mammalian SOS Response. Proceedings of the National Academy of Sciences of the United States of America, 94, 12627-12632.
[13] Longstreth, J.D. (1995) Effects of Increased Solar Radiation on Human Health. Ambio, 24, 153.
[14] Bataille, V., Bishop, J.A., Sasieni, P., et al. (1996) Risk of Cutaneous Melanoma in Relation to the Numbers, Types and Sites of Naevi: A Case-Control Study. British Journal of Cancer, 73, 1605-1611.
[15] Marghoob, A.A. (1999) The Dangers of Atypical Mole (Dysplastic Nevus) Syndrome. Teaching At-Risk Patients to Protect Themselves from Melanoma. Postgraduate Medicine, 105, 147-148, 151-152, 154.
[16] Snels, D.G., Hille, E.T., Gruis, N.A. and Bergman, W. (1999) Risk of Cutaneous Malignant Melanoma in Patients with Nonfamilial Atypical Nevi from a Pigmented Lesions Clinic. Journal of the American Academy of Dermatology, 40, 686-693.
[17] Sauder, D.N. (1999) The Etiology of Malignant Melanoma. Journal of Cutaneous Medicine and Surgery, 3, 287.
[18] Clemente, C., Cochran, A.J., Elder, D.E., Levene, A., Mackie, R.M., Mihm, M.C., et al. (1991) Histopathologic Diagnosis of Dysplastic Nevi: Concordance among Pathologists Convened by the World Health Organization Melanoma Programme. Human Pathology, 22, 313-319.
[19] Skender-Kalmenas, T.M., English, D.R. and Heenan, P.J. (1995) Benign Melanocytic Lesions: Risk Markers of Precursors of Cutaneous Melanoma? Journal of the American Academy of Dermatology, 33, 1000-1007.
[20] Rigel, D.S. (1992) Epidemiology and Prognostic Factors in Malignant Melanoma. Annals of Plastic Surgery, 28, 7-8.
[21] Armstrong, B.K. and English, D.R. (1992) Epidemiologic Studies. In: Balch, C.M., Milton, G.W. and Soong, S.J., Eds., Cutaneous Melanoma, JB Lippinncott, Philadelphia.
[22] Mancianti, M.L., Herlyn, M., Weil, D., Jambrosic, J., Rodeck, U., Becker, D., et al. (1988) Growth and Phenotypic Characteristics of Human Nevus Cells in Culture. Journal of Investigative Dermatology, 90, 134-141.
[23] Westermark, B., Johnsson, A., Paulsson, Y., Betsholtz, C., Heldin, C.H., Herlyn, M., et al. (1986) Human Melanoma Cell Lines of Primary and Metastatic Origin Express the Genes Encoding the Chains of Platelet-Derived Growth Factor PDGF and Produce a PDGF-Like Growth Factor. Proceedings of the National Academy of Sciences of the United States of America, 83, 7197-7200.
[24] Bizik, J., Felnerova, D., Grofova, M. and Vaheri, A. (1996) Active Transforming Growth Factor-Beta in Human Melanoma Cell Lines: No Evidence for Plasmin-Related Activation of Latent TGF-Beta. Journal of Cellular Biochemistry, 62, 113-122.
[25] Reed, J.A., McNutt, N.S., Prieto, V.G. and Albino, A.P. (1994) Expression of Transforming Growth Factor Beta 2 in Malignant Melanoma Correlates with the Depth of Tumor Invasion. Implications for Tumor Progression. American Journal of Pathology, 145, 97-104.
[26] Bennicelli, J.L., Elias, J., Kern, J. and Guerry, D. (1989) Production of Interleukin 1 Activity by Cultured Human Melanoma Cells. Cancer Research, 49, 930-935.
[27] Scheibenbogen, C., Möhler, T., Haefele, J., Hunstein, W. and Keilholz, U. (1995) Serum Interleukin-8 (IL-8) as Elevated in Patients with Metastatic Melanoma and Correlates with Tumor Load. Melanoma Research, 5, 179.
[28] Dummer, W., Becker, J.C., Schwaaf, A., Leverkus, M., Moll, T. and Bröcker, E.B. (1995) Elevated Serum Levels of Interleukin-10 in Patients with Metastatic Malignant Melanoma. Melanona Research, 5, 67.
[29] Thompson, F.H., Emerson, J., Olson, S., Weinstein, R., Leavitt, S.A., Leong, S.P.L., et al. (1995) Cytogenetics of 158 Patients with Regional or Disseminated Melanoma Subset Analysis of Near-Diploid and Simple Karyotypes. Cancer Genetics and Cytogenetics, 83, 93-104.
[30] Glendening, J.M., Flores, J.F., Walker, G.J., Stone, S., Albino, A.P. and Fountain, J.W. (1995) Homozygous Loss of the p15INK4B Gene (and Not the p16INK4 Gene) during tumor Progression in a Sporadic Melanoma Patient. Cancer Research, 55, 5531-5535.
[31] Kamb, A., Gruis, N.A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S.V., et al. (1994) A Cell Cycle Regulator Potentially Involved in the Genesis of Many Tumor Types. Science, 364, 436-440.
[32] Monzon, J., Liu, L., Brill, H., Goldstein, A.M., Tucker, M.A., From, L., et al. (1998) CDKN2A Mutations in Multiple Primary Melanomas. The New England Journal of Medicine, 338, 879-887.

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.